A phase Ib/II, open-label, multicenter, dose-escalation and dose-expansion study of NKTR-255 plus cetuximab as a salvage regimen in patients with solid tumors Meeting Abstract
| Authors: | Altan, M.; Patnaik, A.; Barve, M. A.; Dunn, L.; Cobb, P. W.; Rosenberg, A.; Sharma, S.; Sukari, A.; Lee, Z.; Marcondes, M. Q.; Zalevsky, J.; Tagliaferri, M. A.; Kotzin, B.; Sacco, A. G. |
| Abstract Title: | A phase Ib/II, open-label, multicenter, dose-escalation and dose-expansion study of NKTR-255 plus cetuximab as a salvage regimen in patients with solid tumors |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S860 |
| End Page: | S861 |
| Language: | English |
| ACCESSION: | WOS:000700527702044 |
| DOI: | 10.1016/j.annonc.2021.08.1410 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #1026TiP -- Source: Wos |
